DLC1 and hepatocellular carcinoma: Mechanistically, we demonstrate that depletion of MKL1/2 activates the oncogene Ras in DLC1-deficient HCC cells, resulting in increased levels of pERK (ERKpT202/pY204) (Fig 7).